We investigated the effect of short-term cytokine exposure on defined cord blood subpopulations. 
typic profile according to their origin. [1] [2] [3] [4] [5] There is, however, general consensus that cells capable of long-term hematopoietic repopulation express the CD34 antigen. 6 Moreover, there is considerable compelling evidence to suggest that CD34 ϩ CD38 Ϫ cells are responsible for long-term hematopoietic repopulation.
7-10 CD34 ϩ Thy1 ϩ cells have also been shown to be responsible for disease-free hematopoietic reconstitution. 11, 12 Functional assays have also been used to define stem cell characteristics and results emphasise the quiescent nature of hematopoietic stem cells. 13, 14 The ability of stem and progenitor cells to proliferate in response to cytokine stimulation has formed the basis for the development of cytokine-mediated expansion technology. Interestingly not all stem cells proliferate after short-term cytokine exposure. Traycoff et al 15 
evaluated the expansion potential of cord blood (CB) CD34
ϩ cells monitoring cell proliferation with the cell tracking dye PKH-2. Their results demonstrated that a substantial proportion of primitive long-term hematopoietic culture-initiating cells (LTHC-IC) remained quiescent despite cytokine stimulation. We have previously shown that short-term exposure of CB CD34 ϩ cells to cytokines causes a small proportion of cells to retain their input characteristics. 16 flt3 ligand (flt3L) has been shown to act directly on quiescent cells causing them to enter the cycle. flt3L has been shown to induce proliferation of CD34 ϩ CD38 Ϫ bone marrow (BM) and CB cells that are non-responsive to other early acting cytokines. [17] [18] [19] Shapiro et al 20 suggested that flt3 in combination with other cytokines can be used for short-term expansion of hematopoietic progenitors and facilitates the possible expansion of quiescent primitive cells. Further studies by Haylock et al 21 and Dooley et al 22 support this finding and provide evidence that flt3L acts preferentially on CD34 ϩ CD38 Ϫ cells. Several groups have investigated the coexpression of differentiation-associated antigens on CD34 ϩ cells and the respective in vitro growth potential of CD34 ϩ cells derived from CB, 4, 23 BM 23, 24 and mobilised peripheral blood. 25 However, few studies have investigated the functional and phenotypic characteristics of different CB subpopulations after short-term cytokine exposure. 26 Experiments were therefore designed to investigate the effect of short-term cytokine exposure on defined CB stem cell populations. 
Functional and phenotypic stem cell traits were assessed before and after cytokine exposure. We hypothesized that nucleated cell and progenitor expansion were derived from CB cells with a more mature phenotype and that the primitive stem cell candidates would have a limited proliferative response to short-term cytokine exposure. 
Materials and methods

Collection
Cytokines
Recombinant human (rh) cytokines were used throughout the study. rhInterleukin-3 (IL3), IL6 and rhgranulocytemacrophage colony-stimulating factor (GM-CSF), used at 10 ng/ml were generous gifts of Sandoz, Basel, Switzerland. rhStem cell factor (SCF) and rhG-CSF, used at 10 ng/ml, were generous gifts from Amgen, Melbourne, Australia. flt3L, used at 50 ng/ml, was a generous gift of Dr S Lyman, Immunex, Seattle, WA, USA. rhErythropoietin (Epo), used at 5 U/ml, was a generous gift of Dr J Adams, Janssen-Cilag, Sydney, Australia.
Cytokine-mediated expansion and evaluation
CB CD34
ϩ subpopulations (1 ϫ 10 3 -1 ϫ 10 4 /ml) were incubated in IMDM ϩ 10% FCS with either IL3 ϩ IL6 ϩG ϪCSF ϩ SCF or IL3 ϩ IL6 ϩ GϪCSF ϩ SCF ϩ flt3L for 7 days at 37°C in a fully humidified 5% CO 2 atmosphere. Cells were harvested by vigorous pipetting and rinsing of the tissue culture flasks after the 7 day incubation period. The cells were washed once with PBS and cultures were evaluated for viable nucleated cell count by Trypan blue exclusion, percentage and absolute number of CD34 ϩ cells by immunostaining and stem cell content as measured by LTHC-IC. Full details of assays are given below. These parameters were evaluated before (input) and after (output) cytokine-mediated expansion to analyze the effects of cytokines on the CD34 ϩ subpopulations. 29 
Flow cytometry
Flow cytometry was used to evaluate the immunophenotype of cells after 7 days of cytokine exposure and to establish the pattern of antigen co-expression by CD34 ϩ cells. Cells that had been exposed to cytokines for 7 days were incubated with 20 l of human intravenous Ig (IVIg) 10 mg/ml for 10 min to block nonspecific binding to Fc receptors. 19 Cells were then incubated with CD34-FITC (HPCA-2, Becton Dickinson), CD38-PE (Leu-17, Becton Dickinson) and HLA-DR-PerCp (Becton Dickinson) or isotype control (Simultest, ␥1-FITC-␥2-PE, ␥2a-PerCp, Becton Dickinson), or CD45/CD14 (LeucoGATE, AntiHLe-1/LeuM3, Becton Dickinson) for 30 min at 4°C. The cells were washed twice with 1 ml PBS ϩ 2% bovine serum albumin (BSA) ϩ 0.1% sodium azide to remove unbound antibody and fixed in 1 ml PBS ϩ 1% paraformaldehyde (PFA) prior to analysis. Flow cytometric data acquisition and analysis was performed with Lysis II software on a Becton Dickinson FACScan. Gates were set to include the CD45/CD14-positive population and at least 10 000 events were collected per sample.
To evaluate antigen coexpression by CD34 ϩ cells, MACS enriched CD34 ϩ cells were stained with CD34-PECy5 (Immunotech-Coulter, Sydney, Australia) or CD34-PE and both CD38-PE and HLA-DR-FITC or Thy1-PE and HLA-DR-FITC or Thy1-PE and CD38-FITC or Rh123 and HLA-DR-PerCp or Rh123 and Thy1-PE or Rh123 and CD38-PE. The MACS enriched CD34 ϩ cells were also stained with the relevant isotype controls. The same regions as those used for sorting, with the exception of CD38 where we also included a region to define the CD38 dim cells (R12), were established (Figure 1 ). At least 100 000 events were collected per sample.
Long-term hematopoietic culture-initiating cell assay
Input CB CD34 ϩ subpopulations and expanded cells (output) were evaluated for LTHC-IC using the method described by Traycoff et al. 15 Briefly, LTHC-IC were evaluated by incubating input subpopulations (2, 4, 8, 16 cells/well) and output subpopulations (8, 16, 32 , 64 cells/well) at limiting dilution in 96-well plates in IMDM ϩ 10%FCS containing (10 ng/ml) IL3 ϩ (10 ng/ml) IL6 ϩ (10 ng/ml) GM-CSF ϩ (10 ng/ml) SCF ϩ (5 U/ml) Epo. The cells were incubated for 7 days, re-fed with media and cytokines and incubated for a further 7 days. Fourteen days after the initiation of the culture, 75% of the medium was removed and the remaining cells overlaid with methylcellulose and IL3 ϩ IL6 ϩ GM Ϫ CSF ϩ SCF ϩ Epo. The plates were incubated for 14 days, after which they were scored for clonogenic growth. Wells were considered positive, indicating the presence of at least one LTHC-IC in the original cell inoculum, if one or more hematopoietic colonies per well were detected. The number of positive and negative wells per cell dose was calculated and the data used to establish the frequency of LTHC-IC per cell population.
Statistical analysis
Results, frequency (%), fold increase relative to flt3L or absolute numbers, were expressed as the mean Ϯ standard error of the mean (s.e.m.). Absolute numbers of CD34 Statistical analyses were performed using the Stat Works program and the paired Student's t-test was used to evaluate statistical significance. P р 0.05 was considered statistically significant. 
Results
Nucleated cell expansion
Rh123
Ϫ (P ϭ 0.001)). We were unable to demonstrate a significant difference in nucleated cell expansion for cells sorted on the basis of HLA-DR expression.
The addition of flt3L to IL3 ϩ IL6 ϩ G-CSF ϩ SCF increased the number of nucleated cells in each CD34
ϩ subpopulation. The most pronounced effect of the addition of flt3L to the cytokine cocktail was seen in the CD34 ϩ 38 Ϫ and the CD34 ϩ Rh123 Ϫ subpopulations, although this did not reach statistical significance (Figure 2a-d) .
Immunophenotype after short-term cytokine exposure
Cells from each subpopulation were evaluated for CD34, CD38 and HLA-DR expression after the 7 day incubation period with the different cytokine combinations. Cells remaining CD34
ϩ were expressed as a percentage of the starting population. Stem cell candidates have a higher proportion of cells remaining CD34 ϩ after short-term cytokine exposure than their more mature counterparts (CD34
Rh123
ϩ vs CD34 ϩ Rh123 Ϫ (P ϭ 0.028)). The addition of flt3L to the cytokine cocktail did not alter the percentage of cells expressing the CD34 antigen or the fact that the stem cell candidates have a higher percentage of cells remaining CD34 ϩ after cytokine exposure (Figure 3a-d Ϫ have a higher frequency of cells with a primitive phenotype after short-term cytokine exposure, particularly when the cells had been stimulated with IL3ϩ IL6 ϩ G-CSF ϩ SCF (Table 1) .
CD34 ϩ cell expansion
Limited CD34 ϩ cell expansion was demonstrated from all CD34 ϩ subpopulations, with the exception of CD34 ϩ cells sorted on the basis of Rh123 retention, after short-term cytokine exposure. The addition of flt3L to the cytokine combination had a more marked effect on CD34 ϩ cell expansion from stem cell candidates than that seen with 
were incubated for 7 days with IL3 + IL6 + G-CSF + SCF Ϯ flt3L. CD34 status was evaluated before and after culture. Results are expressed as the percentage of cells remaining CD34 ϩ after culture as compared to the purity of the cell populations used to initiate the cultures. 
mature CD34
ϩ cells, although this did not reach statistical significance (Figure 4a-d) .
Input LTHC-IC
All CD34
ϩ subpopulations gave rise to LTHC-IC. However the mature CD34 ϩ subpopulations, as defined by expression of the CD38 antigen or lack of the Thy1 antigen, contained a significantly higher frequency of LTHC-IC than the stem cell candidates (CD34 ϩ 38 ϩ vs CD34 ϩ 38 Ϫ P ϭ 0.031; CD34 ϩ Thy1 Ϫ vs CD34 ϩ Thy1 ϩ P ϭ 0.02). We were unable to detect a difference in the frequency of LTHC-IC for CD34 ϩ cells sorted on the basis of HLA-DR expression or Rh123 retention ( Figure 5 ).
Frequency of LTHC-IC after short-term cytokine exposure
Stem cell candidates tend not only to have a higher frequency of LTHC-IC than their mature counterparts after short-term cytokine exposure, but also to retain a greater proportion of their input LTHC-IC (CD34 ϩ 38
Moreover, the addition of flt3L did not change the percentage of cells still able to give rise to LTHC-IC (CD34 ϩ 38 (Figure 6a-d) . 
were incubated for 7 days with IL3 ϩ IL6 ϩ G-CSF ϩ SCF Ϯ flt3L. Absolute numbers of CD34 ϩ cells were assessed before and after culture. Results are expressed as Delta values. 
were assessed for LTHC-IC content as described in the Materials and methods. Results are expressed as percentages.
LTHC-IC expansion
All CD34
ϩ subpopulations demonstrated an increase in absolute numbers of LTHC-IC. The addition of flt3L to IL3 ϩ IL6 ϩ G-CSF ϩ SCF further increased absolute numbers of LTHC-IC among the stem cell candidates as compared with that obtained from mature cells (Figure 7a-d) .
Three-color analysis of CD34
ϩ subpopulations
We performed three-color flow cytometric analysis of MACS enriched CD34 ϩ cells to assess the coexpression of other antigens using the same regions as those used for sorting. CD34 ϩ cells expressing CD38 were divided into (Figure 8a-g ).
Discussion
We evaluated the phenotypic and functional characteristics of different CB CD34 ϩ subpopulations after short-term cytokine exposure. Our results show that CB stem cell candidates (CD34 ϩ 38 Ϫ , CD34 ϩ Thy1 ϩ , and CD34 ϩ Rh123 Ϫ ) have a limited proliferative response to short-term cytokine exposure. The results show that nucleated cell expansion is derived from mature CD34 ϩ subpopulations, further supporting the observation that stem cell candidates have a limited proliferative response to cytokines. The addition of flt3 ligand doubles nucleated cell expansion in all CD34 ϩ subpopulations. Interestingly, flt3 ligand had a more pro- The percentage of cells still able to give rise to LTHC-IC after short-term cytokine exposure.
were incubated for 7 days with IL3 ϩ IL6 ϩ G-CSF ϩ SCF Ϯ flt3L. Results are expressed as the percentage of LTHC-IC remaining after culture as compared to percentage of cells that gave rise to LTHC-IC from the freshly sorted subpopulations used to initiate the cultures. nounced effect on stem cell candidates, with the most marked increase in nucleated cell numbers being in the CD34 ϩ 38 Ϫ population. Consequently, these populations were observed to contain a higher proportion of cells with a primitive phenotype after short-term cytokine exposure. These results are in agreement with those of Haylock et al 21 and Dooley et al 22 that showed that flt3 ligand recruits quiescent primitive stem cells into cell cycle.
Stem cell candidates have a higher proportion of cells remaining CD34 ϩ after short-term cytokine exposure than their more mature counterparts, irrespective of the cytokine combination used to stimulate the cells. Expansion of absolute numbers of CD34 ϩ cells was primarily observed among the mature CD34 ϩ subpopulations. These observations further confirm that the numerical expansion seen after short-term cytokine exposure is derived from the mature CD34 ϩ subpopulations and not the stem cell candidates. Whilst the addition of flt3L to the cytokine combination increased the number of CD34 ϩ cells generated, it would seem from the phenotype breakdown that there were fewer CD34 ϩ CD38 Ϫ cells after expansion of CD34 ϩ CD38 Ϫ cells with IL3 ϩ IL6 ϩ G-CSF ϩ SCF ϩ flt3L as compared with the same cells when expanded with IL3 ϩ IL6 ϩG-CSF ϩ SCF.
Stem cell candidates tend not only to have a higher frequency of LTHC-IC than their mature counterparts after short-term cytokine exposure, but also to retain a greater proportion of their input LTHC-IC, irrespective of the cytokine combination used to stimulate the cells. All CD34 ϩ subpopulations demonstrated an increase in absolute numbers of LTHC-IC after cytokine exposure. Interestingly, the addition of flt3L to IL3 ϩ IL6 ϩ G-CSF ϩ SCF substantially increased absolute numbers of LTHC-IC among the stem cell candidates as compared with that obtained from mature cells. However, we could not determine if the LTHC-IC generated from CD34 ϩ cells were capable of giving rise to de novo LTHC-IC.
Our results suggest, in contrast to other reports, 2 that HLA-DR expression by CB CD34 ϩ cells does not define a CB stem cell candidate population. We were unable to detect differences in their LTHC-IC content before and after cytokine exposure as was evident with CD34 ϩ CD38 Ϫ cells express the Thy1 antigen, they appear to be more resistant to cytokine stimulation than the CD34 ϩ Thy1 ϩ subpopulation. Evidence for this is the lower observed nucleated cell expansion, the greater observed percentage of cells remaining CD34 ϩ after cytokine stimulation, the greater observed percentage of cells remaining LTHC-IC and the greatest increase in nucleated cell number in response to the addition of flt3 ligand to the cytokine combination. These results confirm the quiescent nature of CD34 ϩ 38 Ϫ population, are in accordance with De Wynter et al 26 and reflect the stimulatory effect of flt3L on quiescent cells. [19] [20] [21] [22] In conclusion these studies suggest that cord blood stem cell candidates (CD34 ϩ Thy1 ϩ , CD34 ϩ 38 Ϫ , or CD34 ϩ Rh123 Ϫ ) have a limited capacity to proliferate and differentiate after short-term cytokine exposure. This limited capacity to proliferate may be an in-built protection mechanism for stem cells. Our results show a hierarchy within the stem cell candidates suggesting that the CD34 ϩ CD38 Ϫ subpopulation is the most primitive cell type within the CB stem cell pool, a finding that has been substantiated by in vivo studies. 7, 9, 10, 30 Nucleated cell and progenitor expansion would appear to be derived from the mature CD34 ϩ subpopulations. The clinical relevance of this observation is that short-term cytokine exposure could be used to rapidly augment the number of mature cells, without depleting the stem cell pool, in a transplant product to overcome the potentially dangerous infectious and bleeding complications associated with autologous and allogeneic transplantation.
